Lifyorli (relacorilant) is a new medicine used to treat certain types of cancer. The FDA approved Lifyorli in March 2026 to be used in combination with a particular chemotherapy medicine (paclitaxel) ...

How Does Libtayo Work for Non-Small-Cell Lung Cancer (NSCLC)? Libtayo is a specific kind of medicine called immunotherapy. Immunotherapies work by helping your body’s own immune system work to fight ...

(CNN) — Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference ...

DNA repair proteins act like the body's editors, constantly finding and reversing damage to our genetic code. Researchers have long struggled to understand how cancer cells hijack one of these ...

Designation from the National Cancer Institute is a prestigious marker of research excellence. The status was created in 1971 as part of a national strategy to find better treatments for cancer.

At first glance, dinosaur fossils and modern cancer research may seem worlds apart. But a new study suggests that soft tissue preserved for millions of years inside ancient bones could offer valuable ...